You can buy or sell Exact Sciences and other stocks, options, ETFs, and crypto commission-free!
Exact Sciences Corporation Common Stock, also called Exact Sciences, is a molecular diagnostics company, which focuses on the early detection and prevention of colorectal cancer. It developed Cologuard, a screening test for the early detection of colorectal cancer and pre-cancer. Read More The company was founded on February 10, 1995 and is headquartered in Madison, WI.
52 Week High
52 Week Low
Yahoo FinanceMar 1
7 Strong Buy Stocks the Street Loves
Which top stocks are Wall Street analysts the most bullish on? I mean stocks with no “hold” or “sell” ratings and a pure “strong buy” analyst consensus. These are the strong buy stocks that make the most compelling investing opportunities and are definitely worth keeping a close eye on. Using TipRanks powerful stock screener, I set out to pinpoint seven stocks that command the unanimous support of the Street. You can customize the screener settings to match your investment strategy. In this case, I selecte...
Simply Wall StFeb 28
When Can We Expect A Profit From Exact Sciences Corporation (NASDAQ:EXAS)?
Exact Sciences Corporation’s (NASDAQ:EXAS): Exact Sciences Corporation, a molecular diagnostics company, focuses on developing products for the early detection and prevention of various cancers in the United States.
PR NewswireFeb 27
Cologuard Helps Screen Two Million People for Colorectal Cancer
MADISON, Wis., Feb. 27, 2019 /PRNewswire/ -- In less than five years, more than two million Americans have screened for colorectal cancer with Cologuard. Exact Sciences Corp., which created the groundbreaking product with Mayo Clinic, processed more than one million Cologuard tests in the last year alone. Nearly half of the people screened with Cologuard had not previously been screened for colorectal cancer, the second leading cause of cancer death in the United States.i "Cologuard is changing how America...
Expected Apr 25, After Hours